Association of renal and cardiovascular safety with DPP‐4 inhibitors vs sulfonylureas in type 2 diabetes patients with advanced chronic kidney disease

2021 ◽  
Author(s):  
Chun‐Ting Yang ◽  
Wei‐Hung Lin ◽  
Lun‐Jie Li ◽  
Huang‐Tz Ou ◽  
Shihchen Kuo
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Cardiovascular Safety ◽  
Advanced Chronic Kidney Disease ◽  
Diabetes Patients

Treatment Patterns in Type 2 Diabetes Patients with Chronic Kidney Disease-A Cohort Study

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 536-P
Author(s):  
MICHAEL BLANKENBURG ◽  
CSABA P. KOVESDY ◽  
SELINE EISENRING ◽  
ANNE FETT ◽  
EMILE W. SCHOKKER ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Cohort Study ◽  
Kidney Disease ◽  
Treatment Patterns ◽  
Diabetes Patients

The Role of DPP-4 Inhibitors in Type-2 Diabetes Patients with Chronic Kidney Disease

Pharmacophore ◽  
2021 ◽  
Vol 12 (3) ◽  
pp. 91-94
Author(s):  
Mishal Yousef Alqurashi ◽  
Khalid Faisal Alharthi ◽  
Abdulaziz Abdulrahman Alshehri ◽  
Yazeed Khalid Alharbi ◽  
Mohammad Abdulmunem Sanousi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Diabetes Patients

scholarly journals Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study

Diabetes Care ◽  
2020 ◽  
Vol 43 (10) ◽  
pp. e152-e153 ◽  
Author(s):  
Chieh-Li Yen ◽  
Chao-Yi Wu ◽  
Lai-Chu See ◽  
Yi-Jung Li ◽  
Min-Hua Tseng ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Cohort Study ◽  
Kidney Disease ◽  
Adverse Events ◽  
Advanced Chronic Kidney Disease ◽  
National Cohort
Sign in / Sign up

Export Citation Format

Share Document